Why the many health benefits of CBD could be the reason it gets put out of reach for many consumers. Action Alert! The FDA recently held a Stakeholder Call with the hemp industry to provide further information on the agency’s plans to regulate CBD. Recall that the agency has rejected CBD as a supplement and is working with Congress to develop a “new pathway” for CBD. Details on this new pathway are scarce, but the idea seems to be to regulate CBD more than supplements but less than drugs. Read more.